ATXS
Price
$6.63
Change
+$0.16 (+2.47%)
Updated
Mar 12, 01:52 PM (EDT)
Capitalization
365.69M
57 days until earnings call
VTYX
Price
$1.43
Change
+$0.01 (+0.70%)
Updated
Mar 11 closing price
Capitalization
101.36M
57 days until earnings call
Ad is loading...

ATXS vs VTYX

Header iconATXS vs VTYX Comparison
Open Charts ATXS vs VTYXBanner chart's image
Astria Therapeutics
Price$6.63
Change+$0.16 (+2.47%)
Volume$700
Capitalization365.69M
Ventyx Biosciences
Price$1.43
Change+$0.01 (+0.70%)
Volume$755.96K
Capitalization101.36M
ATXS vs VTYX Comparison Chart
Loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ATXS vs. VTYX commentary
Mar 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATXS is a Buy and VTYX is a Hold.

Ad is loading...
COMPARISON
Comparison
Mar 12, 2025
Stock price -- (ATXS: $6.47 vs. VTYX: $1.43)
Brand notoriety: ATXS and VTYX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ATXS: 136% vs. VTYX: 55%
Market capitalization -- ATXS: $365.69M vs. VTYX: $101.36M
ATXS [@Biotechnology] is valued at $365.69M. VTYX’s [@Biotechnology] market capitalization is $101.36M. The market cap for tickers in the [@Biotechnology] industry ranges from $355.07B to $0. The average market capitalization across the [@Biotechnology] industry is $2.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ATXS’s FA Score shows that 0 FA rating(s) are green whileVTYX’s FA Score has 1 green FA rating(s).

  • ATXS’s FA Score: 0 green, 5 red.
  • VTYX’s FA Score: 1 green, 4 red.
According to our system of comparison, VTYX is a better buy in the long-term than ATXS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ATXS’s TA Score shows that 5 TA indicator(s) are bullish while VTYX’s TA Score has 5 bullish TA indicator(s).

  • ATXS’s TA Score: 5 bullish, 2 bearish.
  • VTYX’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, both ATXS and VTYX are a good buy in the short-term.

Price Growth

ATXS (@Biotechnology) experienced а +4.19% price change this week, while VTYX (@Biotechnology) price change was -2.05% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -1.49%. For the same industry, the average monthly price growth was -7.04%, and the average quarterly price growth was -8.35%.

Reported Earning Dates

ATXS is expected to report earnings on May 08, 2025.

VTYX is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-1.49% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ATXS($366M) has a higher market cap than VTYX($101M). ATXS YTD gains are higher at: -27.629 vs. VTYX (-34.703). ATXS has higher annual earnings (EBITDA): -100.97M vs. VTYX (-164.94M). ATXS has more cash in the bank: 344M vs. VTYX (275M). ATXS has less debt than VTYX: ATXS (5.64M) vs VTYX (11M). ATXS (0) and VTYX (0) have equivalent revenues.
ATXSVTYXATXS / VTYX
Capitalization366M101M362%
EBITDA-100.97M-164.94M61%
Gain YTD-27.629-34.70380%
P/E RatioN/AN/A-
Revenue00-
Total Cash344M275M125%
Total Debt5.64M11M51%
FUNDAMENTALS RATINGS
ATXS: Fundamental Ratings
ATXS
OUTLOOK RATING
1..100
9
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
92
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ATXSVTYX
RSI
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
81%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
Bullish Trend 1 day ago
74%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
84%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
86%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
85%
Advances
ODDS (%)
Bullish Trend 27 days ago
83%
Bullish Trend 23 days ago
86%
Declines
ODDS (%)
Bearish Trend 3 days ago
89%
Bearish Trend 3 days ago
86%
BollingerBands
ODDS (%)
N/A
Bullish Trend 1 day ago
78%
Aroon
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
ATXS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VTYX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
CRYPTO / NAMEPrice $Chg $Chg %
BTC.X82862.2100004330.211000
+5.51%
Bitcoin cryptocurrency
TSLA230.588.43
+3.79%
Tesla
GME22.610.19
+0.85%
GameStop Corp
SPY555.92-4.66
-0.83%
SPDR® S&P 500® ETF Trust
AAPL220.84-6.64
-2.92%
Apple

ATXS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ATXS has been loosely correlated with CRNX. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if ATXS jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ATXS
1D Price
Change %
ATXS100%
+11.17%
CRNX - ATXS
47%
Loosely correlated
+1.51%
KYMR - ATXS
47%
Loosely correlated
+0.76%
IMNM - ATXS
46%
Loosely correlated
-1.36%
ABOS - ATXS
45%
Loosely correlated
+5.83%
CCCC - ATXS
44%
Loosely correlated
-5.09%
More

VTYX and

Correlation & Price change

A.I.dvisor indicates that over the last year, VTYX has been loosely correlated with AKRO. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if VTYX jumps, then AKRO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VTYX
1D Price
Change %
VTYX100%
+0.70%
AKRO - VTYX
37%
Loosely correlated
+5.13%
ATXS - VTYX
36%
Loosely correlated
+11.17%
ARWR - VTYX
35%
Loosely correlated
-0.99%
KYMR - VTYX
35%
Loosely correlated
+0.76%
CCCC - VTYX
35%
Loosely correlated
-5.09%
More